144 related articles for article (PubMed ID: 33676393)
1. Onset of acid-neutralizing action of a calcium/magnesium carbonate-based antacid using an artificial stomach model: an in vitro evaluation.
Voropaiev M; Nock D
BMC Gastroenterol; 2021 Mar; 21(1):112. PubMed ID: 33676393
[TBL] [Abstract][Full Text] [Related]
2. Antacid activity of calcium carbonate and hydrotalcite tablets. Comparison between in vitro evaluation using the "artificial stomach-duodenum" model and in vivo pH-metry in healthy volunteers.
Vatier J; Ramdani A; Vitré MT; Mignon M
Arzneimittelforschung; 1994 Apr; 44(4):514-8. PubMed ID: 8011006
[TBL] [Abstract][Full Text] [Related]
3. Clinical and laboratory studies of the antacid and raft-forming properties of Rennie alginate suspension.
Tytgat GN; Simoneau G
Aliment Pharmacol Ther; 2006 Mar; 23(6):759-65. PubMed ID: 16556178
[TBL] [Abstract][Full Text] [Related]
4. Effect of Rennie Liquid versus Maalox Liquid on intragastric pH in a double-blind, randomized, placebo-controlled, triple cross-over study in healthy volunteers.
Hürlimann S; Michel K; Inauen W; Halter F
Am J Gastroenterol; 1996 Jun; 91(6):1173-80. PubMed ID: 8651166
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the effect of the antacid Rennie versus low-dose H2-receptor antagonists (ranitidine, famotidine) on intragastric acidity.
Netzer P; Brabetz-Höfliger A; Bründler R; Flogerzi B; Hüsler J; Halter F
Aliment Pharmacol Ther; 1998 Apr; 12(4):337-42. PubMed ID: 9690722
[TBL] [Abstract][Full Text] [Related]
6. Comparison of two antacid preparations on intragastric acidity--a two-centre open randomised cross-over placebo-controlled trial.
Sulz MC; Manz M; Grob P; Meier R; Drewe J; Beglinger C
Digestion; 2007; 75(2-3):69-73. PubMed ID: 17496418
[TBL] [Abstract][Full Text] [Related]
7. Absence of rebound effect with calcium carbonate.
Simoneau G
Eur J Drug Metab Pharmacokinet; 1996; 21(4):351-7. PubMed ID: 9074901
[TBL] [Abstract][Full Text] [Related]
8. Two placebo-controlled crossover studies in healthy subjects to evaluate gastric acid neutralization by an alginate-antacid formulation (Gaviscon Double Action).
Wilkinson J; Abd-Elaziz K; den Daas I; Wemer J; van Haastert M; Hodgkinson V; Foster M; Coyle C
Drug Dev Ind Pharm; 2019 Mar; 45(3):430-438. PubMed ID: 30470147
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of buffering capacity and acid neutralizing-pH time profile of antacids.
Lin MS; Sun P; Yu HY
J Formos Med Assoc; 1998 Oct; 97(10):704-10. PubMed ID: 9830281
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the effects of over-the-counter famotidine and calcium carbonate antacid on postprandial gastric acid. A randomized controlled trial.
Feldman M
JAMA; 1996 May; 275(18):1428-31. PubMed ID: 8618369
[TBL] [Abstract][Full Text] [Related]
11. In vitro assessment of antacid efficacy using a computer-controlled 'artificial stomach-duodenum' model reproducing gastroduodenal flux regulation.
Vatier J; Cai S; Célice-Pingaud C; Castela-Papin N; Mignon M; Farinotti R
Therapie; 1996; 51(2):147-54. PubMed ID: 8763049
[TBL] [Abstract][Full Text] [Related]
12. An artificial stomach-duodenum model for the in-vitro evaluation of antacids.
Vatier J; Malikova-Sekera E; Vitre MT; Mignon M
Aliment Pharmacol Ther; 1992 Aug; 6(4):447-58. PubMed ID: 1420737
[TBL] [Abstract][Full Text] [Related]
13. Interests of the 'artificial stomach' techniques to study antacid formulations: comparison with in vivo evaluation.
Vatier J; Célice-Pingaud C; Farinotti R
Fundam Clin Pharmacol; 1998; 12(6):573-83. PubMed ID: 9818289
[TBL] [Abstract][Full Text] [Related]
14. Effects of Aluminum/Magnesium Hydroxide and Calcium Carbonate on Esophageal and Gastric pH in Subjects with Heartburn.
Decktor DL; Robinson M; Maton PN; Lanza FL; Gottlieb S
Am J Ther; 1995 Aug; 2(8):546-552. PubMed ID: 11854825
[TBL] [Abstract][Full Text] [Related]
15. Assessment of antacid characteristics of drugs containing a combination of aluminium and magnesium salts using the "artificial stomach" model.
Vatier J; Vitre MT; Lionnet F; Poitevin C; Mignon M
Arzneimittelforschung; 1990 Jan; 40(1):42-8. PubMed ID: 2339999
[TBL] [Abstract][Full Text] [Related]
16. Radiotelemetric comparison of two antacids using the Heidelberg capsule.
Gómez Puch LM; Ríos Solans G; Muñoz y Fernandez JR
Arzneimittelforschung; 1984; 34(10A):1378-80. PubMed ID: 6548925
[TBL] [Abstract][Full Text] [Related]
17. [In vitro evaluation of antacid activity in gastric acid secretion in static and dynamic systems].
Vatier J; Malikova-Sekera E; Vitre MT; Mignon M
Therapie; 1992; 47(2):99-104. PubMed ID: 1412150
[TBL] [Abstract][Full Text] [Related]
18. [Therapy with antacids].
Holtermüller KH
Fortschr Med; 1979 Jun; 97(23):1068-71, 1087. PubMed ID: 37146
[TBL] [Abstract][Full Text] [Related]
19. Effect of metal-cation antacids on the pharmacokinetics of 1200 mg raltegravir.
Krishna R; East L; Larson P; Valiathan C; Butterfield K; Teng Y; Hernandez-Illas M
J Pharm Pharmacol; 2016 Nov; 68(11):1359-1365. PubMed ID: 27671833
[TBL] [Abstract][Full Text] [Related]
20. Effects of antacid formulation on postprandial oesophageal acidity in patients with a history of episodic heartburn.
Robinson M; Rodriguez-Stanley S; Miner PB; McGuire AJ; Fung K; Ciociola AA
Aliment Pharmacol Ther; 2002 Mar; 16(3):435-43. PubMed ID: 11876696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
